INS and polycystic ovary syndrome: However, some studies reported no differences in insulin-stimulated insulin receptor substrate-1-associated PI3K activity in the skeletal muscle in patients with PCOS, compared with the control (Dunaif et al., 2001; Hojlund et al., 2008).